evobrutinib
merck
['evobrutinib']
how safe are btk inhibitors in ms (data from evobrutinib 2.5 year open label extension study) . serious infections in 9/213 patients (4.2%). 3 were fatal (2 x covid-19 pneumonia, 1 x e coli). some reduction in b-cells was seen. #ectrims2022 
Neurologist and MS specialist. YouTube creator. Author of "Resilience in the Face of Multiple Sclerosis". Father of 2.  Tweets my own & not medical advice.